The DOI matches its Crossref record.
Response Versus Remission in Obsessive-Compulsive Disorder
Abstract
Article Abstract Objective: To investigate rates of response and remission in adults with obsessive-compulsive disorder (OCD) after 12 weeks of evidence-based treatment. Method: Post hoc analyses of response and remission were conducted using data from a multisite, randomized, controlled trial comparing the effects of 12 weeks of exposure and ritual prevention (EX/RP), clomipramine (CMI), their combination (EX/RP+CMI), or pill placebo (PBO) in 122 adults with OCD (DSM-III-R or DSM-IV criteria). Response was defined as a decrease in symptoms; remission was defined as minimal symptoms after treatment. Different response and remission definitions were constructed based on criteria used in prior studies. For each definition, the proportion of responders or remitters in each treatment group was then compared. Results: There were significant differences (p < .05) among the 4 treatment groups in the proportion of responders and remitters. In pairwise comparisons, EX/RP + CMI and EX/RP each produced significantly more responders and remitters than PBO; CMI produced significantly more responders and remitters than PBO for some definitions but not for others. When remission was defined as a Yale-Brown Obsessive Compulsive Scale (YBOCS) score of 12 or less, significantly more EX/RP + CMI (18/31 ) and EX/RP (15/29 ) patients entering treatment achieved remission than either CMI (9/36 ) or PBO (0/26 ) patients. However, even in treatment completers, many CMI and some EX/RP + CMI and EX/RP patients did not achieve remission (remission rates for YBOCS < = 12: EX/RP + CMI = 13/19 ; EX/RP = 15/21 ; CMI = 8/27 ; PBO = 0/20 ). Conclusion: EX/RP (with or without CMI) can lead to superior treatment outcome compared with CMI alone in OCD patients without comorbid depression. However, many OCD patients who receive evidence-based treatment do not achieve remission.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“exposure and response prevention (ERP), which is now considered to be the first-line psychotherapy for the disorder.”
From Exposure and response prevention for obsessive-compulsive disorder: A review and new directions (2019) · cites this paper as [26]
In the citing paper
“only about half of the patients who receive it will reach complete symptom remission.[26]”
From Exposure and response prevention for obsessive-compulsive disorder: A review and new directions (2019) · cites this paper as [26]
In the citing paper
“EX/RP typically helps up to half of patients achieve minimal symptoms after treatment (i.e., remission) (12).”
From Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder (2019) · cites this paper as [12]
In the citing paper
“this cutoff not only reflects minimal symptoms after treatment but also predicts good quality of life and adaptive functioning (12,26,30).”
From Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder (2019) · cites this paper as [12]
In the citing paper
“operationalized as a posttreatment Y-BOCS score ≤ 12, given that this cutoff reflects symptom reduction and predicts good quality of life and adaptive functioning (12,26,30).”
From Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder (2019) · cites this paper as [12]
Citations
Cited by
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028
“Differing definitions of response and remission applied to the data post hoc changed the magnitude but not the significance of these differences in outcome (Simpson et al. 2006).”
BackgroundSelf-citationÖst, L.-G., Havnen, A., Hansen, B., & Kvale, G. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.06.003 · Cited by 655
Mataix‐Cols, D., de la Cruz, L. F., Nordsletten, A. E., Lenhard, F., Isomura, K., & Simpson, H. B. (2016) · World Psychiatry · doi:10.1002/wps.20299 · Cited by 386
Self-citationShould an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?
Phillips, K. A., Stein, D. J., Rauch, S. L., Hollander, E., Fallon, B. A., Barsky, A., Fineberg, N., Mataix-Cols, D., Ferrão, Y. A., Saxena, S., et al. (2010) · Depression and Anxiety · doi:10.1002/da.20705 · Cited by 347
“The response rate to placebo in OCD using the same scale can be much lower, closer to 10%,([309,310]) suggesting that the pathophysiologic mechanisms that perpetuate each of these disorders may differ.”
BackgroundEvidence-based pharmacotherapy of obsessive-compulsive disorder
Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001829 · Cited by 336
Metadata
- Authors
- Simpson, H. B., Huppert, J. D., Petkova, E., Foa, E. B., & Liebowitz, M. R.
- Affiliations
- New York State Psychiatric Institute (US)
- University of Pennsylvania (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-02-15
- Volume
- 67
- Issue
- 02
- Pages
- 269-276
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2011811397
- Cited by
- 241
- References
- 0
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 8 · 2023: 7 · 2022: 14 · 2021: 21 · 2020: 8 · 2019: 17 · 2018: 12 · 2017: 12 · 2016: 13 · 2015: 15 · 2014: 11 · 2013: 15 · 2012: 15
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH045404, R01MH-45404, K23MH001907, MH01907, R01MH045436, R01MH-45436)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- obsessive-compulsive disorder, treatment response, remission, exposure and response prevention, clomipramine, combination therapy, Yale-Brown Obsessive Compulsive Scale, comorbid depression, adults
- MeSH terms
- Adult, Ambulatory Care, Antidepressive Agents, Tricyclic, Clomipramine, Combined Modality Therapy, Female, Humans, Male, Terminology as Topic, Obsessive-Compulsive Disorder, Placebos, Psychiatric Status Rating Scales, Psychometrics, Cognitive Behavioral Therapy, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Response Versus Remission in Obsessive-Compulsive Disorder. https://app.cochat.ai/papers/10.4088/jcp.v67n0214
- The paper
- Simpson, H. B., Huppert, J. D., Petkova, E., Foa, E. B., & Liebowitz, M. R. (2006). Response Versus Remission in Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v67n0214
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.